Alamar Biosciences, Inc. (California) (ALMR)
27.89
+0.12
(+0.43%)
USD |
NASDAQ |
Sep 11, 16:00
27.86
-0.03
(-0.11%)
After-Hours: 20:00
Alamar Biosciences Price to Book Value : 6.186 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.186 |
| September 10, 2026 | 6.159 |
| September 09, 2026 | 6.423 |
| September 08, 2026 | 6.642 |
| September 04, 2026 | 6.831 |
| September 03, 2026 | 6.78 |
| September 02, 2026 | 6.762 |
| September 01, 2026 | 6.512 |
| August 31, 2026 | 6.773 |
| August 28, 2026 | 6.811 |
| August 27, 2026 | 7.319 |
| August 26, 2026 | 7.558 |
| August 25, 2026 | 7.323 |
| August 24, 2026 | 7.252 |
| August 21, 2026 | 7.594 |
| August 20, 2026 | 7.683 |
| August 19, 2026 | 7.882 |
| August 18, 2026 | 7.310 |
| August 17, 2026 | 7.126 |
| August 14, 2026 | 7.354 |
| August 13, 2026 | 7.301 |
| August 12, 2026 | 7.346 |
| August 11, 2026 | 8.111 |
| August 10, 2026 | 6.208 |
| August 07, 2026 | 6.312 |
| Date | Value |
|---|---|
| August 06, 2026 | 6.232 |
| August 05, 2026 | 6.288 |
| August 04, 2026 | 6.013 |
| August 03, 2026 | 6.004 |
| July 31, 2026 | 5.624 |
| July 30, 2026 | 5.560 |
| July 29, 2026 | 5.405 |
| July 28, 2026 | 5.480 |
| July 27, 2026 | 5.412 |
| July 24, 2026 | 5.740 |
| July 23, 2026 | 5.742 |
| July 22, 2026 | 5.571 |
| July 21, 2026 | 5.578 |
| July 20, 2026 | 5.305 |
| July 17, 2026 | 5.755 |
| July 16, 2026 | 5.534 |
| July 15, 2026 | 5.795 |
| July 14, 2026 | 5.999 |
| July 13, 2026 | 6.077 |
| July 10, 2026 | 6.303 |
| July 09, 2026 | 5.873 |
| July 08, 2026 | 5.611 |
| July 07, 2026 | 5.596 |
| July 06, 2026 | 5.691 |
| July 02, 2026 | 5.753 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| 10X Genomics, Inc. | 10.82 |
| Personalis, Inc. | 7.332 |
| Twist Bioscience Corp. | 17.89 |
| Adaptive Biotechnologies Corp. | 26.93 |
| Champions Oncology, Inc. | 18.23 |
Price to Book Value Related Metrics
| PS Ratio | 22.82 |
| Price | 27.89 |
| Earnings Yield | -2.54% |
| Market Cap | 1.935B |